Table of Contents Executive Summary 1 Industry Overview of Crigler-Najjar Syndrome Drug 1.1 Definition of Crigler-Najjar Syndrome Drug 1.2 Crigler-Najjar Syndrome Drug Segment by Type 1.2.1 Global Crigler-Najjar Syndrome Drug Production Growth Rate Comparison by Types (2014-2025) 1.2.2 ALXN-1540 1.2.3 AT-342 1.2.4 HepaStem 1.2.5 Others 1.3 Crigler-Najjar Syndrome Drug Segment by Applications 1.3.1 Global Crigler-Najjar Syndrome Drug Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Global Crigler-Najjar Syndrome Drug Overall Market 1.4.1 Global Crigler-Najjar Syndrome Drug Revenue (2014-2025) 1.4.2 Global Crigler-Najjar Syndrome Drug Production (2014-2025) 1.4.3 North America Crigler-Najjar Syndrome Drug Status and Prospect (2014-2025) 1.4.4 Europe Crigler-Najjar Syndrome Drug Status and Prospect (2014-2025) 1.4.5 China Crigler-Najjar Syndrome Drug Status and Prospect (2014-2025) 1.4.6 Japan Crigler-Najjar Syndrome Drug Status and Prospect (2014-2025) 1.4.7 Southeast Asia Crigler-Najjar Syndrome Drug Status and Prospect (2014-2025) 1.4.8 India Crigler-Najjar Syndrome Drug Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Crigler-Najjar Syndrome Drug 2.3 Manufacturing Process Analysis of Crigler-Najjar Syndrome Drug 2.4 Industry Chain Structure of Crigler-Najjar Syndrome Drug 3 Development and Manufacturing Plants Analysis of Crigler-Najjar Syndrome Drug 3.1 Capacity and Commercial Production Date 3.2 Global Crigler-Najjar Syndrome Drug Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Crigler-Najjar Syndrome Drug 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Crigler-Najjar Syndrome Drug Production and Capacity Analysis 4.2 Crigler-Najjar Syndrome Drug Revenue Analysis 4.3 Crigler-Najjar Syndrome Drug Price Analysis 4.4 Market Concentration Degree 5 Crigler-Najjar Syndrome Drug Regional Market Analysis 5.1 Crigler-Najjar Syndrome Drug Production by Regions 5.1.1 Global Crigler-Najjar Syndrome Drug Production by Regions 5.1.2 Global Crigler-Najjar Syndrome Drug Revenue by Regions 5.2 Crigler-Najjar Syndrome Drug Consumption by Regions 5.3 North America Crigler-Najjar Syndrome Drug Market Analysis 5.3.1 North America Crigler-Najjar Syndrome Drug Production 5.3.2 North America Crigler-Najjar Syndrome Drug Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Crigler-Najjar Syndrome Drug Import and Export 5.4 Europe Crigler-Najjar Syndrome Drug Market Analysis 5.4.1 Europe Crigler-Najjar Syndrome Drug Production 5.4.2 Europe Crigler-Najjar Syndrome Drug Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Crigler-Najjar Syndrome Drug Import and Export 5.5 China Crigler-Najjar Syndrome Drug Market Analysis 5.5.1 China Crigler-Najjar Syndrome Drug Production 5.5.2 China Crigler-Najjar Syndrome Drug Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Crigler-Najjar Syndrome Drug Import and Export 5.6 Japan Crigler-Najjar Syndrome Drug Market Analysis 5.6.1 Japan Crigler-Najjar Syndrome Drug Production 5.6.2 Japan Crigler-Najjar Syndrome Drug Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Crigler-Najjar Syndrome Drug Import and Export 5.7 Southeast Asia Crigler-Najjar Syndrome Drug Market Analysis 5.7.1 Southeast Asia Crigler-Najjar Syndrome Drug Production 5.7.2 Southeast Asia Crigler-Najjar Syndrome Drug Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Crigler-Najjar Syndrome Drug Import and Export 5.8 India Crigler-Najjar Syndrome Drug Market Analysis 5.8.1 India Crigler-Najjar Syndrome Drug Production 5.8.2 India Crigler-Najjar Syndrome Drug Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Crigler-Najjar Syndrome Drug Import and Export 6 Crigler-Najjar Syndrome Drug Segment Market Analysis (by Type) 6.1 Global Crigler-Najjar Syndrome Drug Production by Type 6.2 Global Crigler-Najjar Syndrome Drug Revenue by Type 6.3 Crigler-Najjar Syndrome Drug Price by Type 7 Crigler-Najjar Syndrome Drug Segment Market Analysis (by Application) 7.1 Global Crigler-Najjar Syndrome Drug Consumption by Application 7.2 Global Crigler-Najjar Syndrome Drug Consumption Market Share by Application (2014-2019) 8 Crigler-Najjar Syndrome Drug Major Manufacturers Analysis 8.1 Audentes Therapeutics Inc 8.1.1 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Production Sites and Area Served 8.1.2 Audentes Therapeutics Inc Product Introduction, Application and Specification 8.1.3 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Genethon SA 8.2.1 Genethon SA Crigler-Najjar Syndrome Drug Production Sites and Area Served 8.2.2 Genethon SA Product Introduction, Application and Specification 8.2.3 Genethon SA Crigler-Najjar Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 International Stem Cell Corp 8.3.1 International Stem Cell Corp Crigler-Najjar Syndrome Drug Production Sites and Area Served 8.3.2 International Stem Cell Corp Product Introduction, Application and Specification 8.3.3 International Stem Cell Corp Crigler-Najjar Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Promethera Biosciences SA 8.4.1 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Production Sites and Area Served 8.4.2 Promethera Biosciences SA Product Introduction, Application and Specification 8.4.3 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 9 Development Trend of Analysis of Crigler-Najjar Syndrome Drug Market 9.1 Global Crigler-Najjar Syndrome Drug Market Trend Analysis 9.1.1 Global Crigler-Najjar Syndrome Drug Market Size (Volume and Value) Forecast 2019-2025 9.2 Crigler-Najjar Syndrome Drug Regional Market Trend 9.2.1 North America Crigler-Najjar Syndrome Drug Forecast 2019-2025 9.2.2 Europe Crigler-Najjar Syndrome Drug Forecast 2019-2025 9.2.3 China Crigler-Najjar Syndrome Drug Forecast 2019-2025 9.2.4 Japan Crigler-Najjar Syndrome Drug Forecast 2019-2025 9.2.5 Southeast Asia Crigler-Najjar Syndrome Drug Forecast 2019-2025 9.2.6 India Crigler-Najjar Syndrome Drug Forecast 2019-2025 9.3 Crigler-Najjar Syndrome Drug Market Trend (Product Type) 9.4 Crigler-Najjar Syndrome Drug Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Crigler-Najjar Syndrome Drug Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Crigler-Najjar Syndrome Drug Table Global Crigler-Najjar Syndrome Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Crigler-Najjar Syndrome Drug Production Market Share by Types in 2018 Figure ALXN-1540 Product Picture Figure AT-342 Product Picture Figure HepaStem Product Picture Figure Others Product Picture Table Global Crigler-Najjar Syndrome Drug Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Crigler-Najjar Syndrome Drug Consumption Market Share by Applications in 2018 Figure Hospital Figure Clinic Figure Others Figure Global Crigler-Najjar Syndrome Drug Revenue (Million USD) (2014-2025) Figure Global Crigler-Najjar Syndrome Drug Production (K Pcs) (2014-2025) Figure North America Crigler-Najjar Syndrome Drug Market Size (Million USD) (2014-2025) Figure Europe Crigler-Najjar Syndrome Drug Market Size (Million USD) (2014-2025) Figure China Crigler-Najjar Syndrome Drug Market Size (Million USD) (2014-2025) Figure Japan Crigler-Najjar Syndrome Drug Market Size (Million USD) (2014-2025) Figure Southeast Asia Crigler-Najjar Syndrome Drug Market Size (Million USD) (2014-2025) Figure India Crigler-Najjar Syndrome Drug Market Size (Million USD) (2014-2025) Table Crigler-Najjar Syndrome Drug Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Crigler-Najjar Syndrome Drug in 2018 Figure Manufacturing Process Analysis of Crigler-Najjar Syndrome Drug Figure Industry Chain Structure of Crigler-Najjar Syndrome Drug Table Capacity and Commercial Production Date of Key Manufacturers Table Global Crigler-Najjar Syndrome Drug Manufacturing Plants Distribution Table Crigler-Najjar Syndrome Drug Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Crigler-Najjar Syndrome Drug Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Crigler-Najjar Syndrome Drug Production (K Pcs) of Major Manufacturers (2014-2019) Table Crigler-Najjar Syndrome Drug Production Market Share of Major Manufacturers (2014-2019) Figure Crigler-Najjar Syndrome Drug Production Share by Manufacturers in 2018 Table Crigler-Najjar Syndrome Drug Revenue (Million US$) of Major Manufacturers (2014-2019) Table Crigler-Najjar Syndrome Drug Revenue Market Share of Major Manufacturers (2014-2019) Figure Crigler-Najjar Syndrome Drug Revenue Share by Manufacturers in 2018 Table Crigler-Najjar Syndrome Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Crigler-Najjar Syndrome Drug Production by Regions 2014-2019 (K Pcs) Table Global Crigler-Najjar Syndrome Drug Production Market Share by Regions 2014-2019 Figure Global Crigler-Najjar Syndrome Drug Production Market Share by Regions in 2018 Table Global Crigler-Najjar Syndrome Drug Revenue by Regions 2014-2019 (Million USD) Table Global Crigler-Najjar Syndrome Drug Revenue Market Share by Regions 2014-2019 Figure Global Crigler-Najjar Syndrome Drug Revenue Market Share by Regions in 2018 Table Global Crigler-Najjar Syndrome Drug Consumption by Regions 2014-2019 (K Pcs) Table Global Crigler-Najjar Syndrome Drug Consumption Market Share by Regions 2014-2019 Figure North America Crigler-Najjar Syndrome Drug Production Growth Rate 2014-2019 (K Pcs) Figure North America Crigler-Najjar Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD) Table North America Crigler-Najjar Syndrome Drug Production, Consumption Import and Export (K Pcs) Figure Europe Crigler-Najjar Syndrome Drug Production Growth Rate 2014-2019 (K Pcs) Figure Europe Crigler-Najjar Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD) Table Europe Crigler-Najjar Syndrome Drug Production, Consumption Import and Export (K Pcs) Figure China Crigler-Najjar Syndrome Drug Production Growth Rate 2014-2019 (K Pcs) Figure China Crigler-Najjar Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD) Table China Crigler-Najjar Syndrome Drug Production, Consumption Import and Export (K Pcs) Figure Japan Crigler-Najjar Syndrome Drug Production Growth Rate 2014-2019 (K Pcs) Figure Japan Crigler-Najjar Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD) Table Japan Crigler-Najjar Syndrome Drug Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Crigler-Najjar Syndrome Drug Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Crigler-Najjar Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Crigler-Najjar Syndrome Drug Production, Consumption Import and Export (K Pcs) Figure India Crigler-Najjar Syndrome Drug Production Growth Rate 2014-2019 (K Pcs) Figure India Crigler-Najjar Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD) Table India Crigler-Najjar Syndrome Drug Production, Consumption Import and Export (K Pcs) Figure Global Consumption Crigler-Najjar Syndrome Drug Market Share by Application (2014-2019) Figure Global Value (Consumption) Crigler-Najjar Syndrome Drug Market Share by Application (2014-2019) Table Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Production Sites and Area Served Table Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Product Introduction, Application and Specification Table Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Production Growth Rate (2014-2019) Table Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Production Market Share (2014-2019) Figure Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Revenue Market Share (2014-2019) Table Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Main Business and Markets Served Table Genethon SA Crigler-Najjar Syndrome Drug Production Sites and Area Served Table Genethon SA Crigler-Najjar Syndrome Drug Product Introduction, Application and Specification Table Genethon SA Crigler-Najjar Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Genethon SA Crigler-Najjar Syndrome Drug Production Growth Rate (2014-2019) Table Genethon SA Crigler-Najjar Syndrome Drug Production Market Share (2014-2019) Figure Genethon SA Crigler-Najjar Syndrome Drug Revenue Market Share (2014-2019) Table Genethon SA Crigler-Najjar Syndrome Drug Main Business and Markets Served Table International Stem Cell Corp Crigler-Najjar Syndrome Drug Production Sites and Area Served Table International Stem Cell Corp Crigler-Najjar Syndrome Drug Product Introduction, Application and Specification Table International Stem Cell Corp Crigler-Najjar Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table International Stem Cell Corp Crigler-Najjar Syndrome Drug Production Growth Rate (2014-2019) Table International Stem Cell Corp Crigler-Najjar Syndrome Drug Production Market Share (2014-2019) Figure International Stem Cell Corp Crigler-Najjar Syndrome Drug Revenue Market Share (2014-2019) Table International Stem Cell Corp Crigler-Najjar Syndrome Drug Main Business and Markets Served Table Promethera Biosciences SA Crigler-Najjar Syndrome Drug Production Sites and Area Served Table Promethera Biosciences SA Crigler-Najjar Syndrome Drug Product Introduction, Application and Specification Table Promethera Biosciences SA Crigler-Najjar Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Promethera Biosciences SA Crigler-Najjar Syndrome Drug Production Growth Rate (2014-2019) Table Promethera Biosciences SA Crigler-Najjar Syndrome Drug Production Market Share (2014-2019) Figure Promethera Biosciences SA Crigler-Najjar Syndrome Drug Revenue Market Share (2014-2019) Table Promethera Biosciences SA Crigler-Najjar Syndrome Drug Main Business and Markets Served Figure Global Crigler-Najjar Syndrome Drug Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Crigler-Najjar Syndrome Drug Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Crigler-Najjar Syndrome Drug Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Crigler-Najjar Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Crigler-Najjar Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Crigler-Najjar Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Crigler-Najjar Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Crigler-Najjar Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Crigler-Najjar Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Crigler-Najjar Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Crigler-Najjar Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Crigler-Najjar Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Crigler-Najjar Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Crigler-Najjar Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Crigler-Najjar Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Crigler-Najjar Syndrome Drug by Type (2019-2025) Table Global Consumption (K Pcs) of Crigler-Najjar Syndrome Drug by Application (2019-2025) Table Crigler-Najjar Syndrome Drug Distributors List Table Crigler-Najjar Syndrome Drug Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Audentes Therapeutics Inc Genethon SA International Stem Cell Corp Promethera Biosciences SA